Quantcast
Scientists Find Control Signal For Immune System That Could

Scientists Find Control Signal For Immune System That Could Help Treat Autoimmune Diseases And Cancer

Salk Institute When faced with pathogens, the immune system summons a swarm of cells made up of soldiers and peacekeepers. The peacekeeping cells tell the soldier cells to halt fighting when invaders are cleared. Without this cease-fire...

Latest autoimmune disease Stories

2014-08-27 08:27:25

ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc. (OTCQB: TNIB), ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced it had received payment and will make its first shipments of Lodonal(®) to the Republic of Panama and The Republic of Malawi in conjunction with our marketing partner, The Brewer Group, Inc. Commenting on the initial shipments, Noreen...

2014-08-05 08:34:27

Supports progression of this first-in-class anti-TLR4 monoclonal antibody into clinical proof of concept study as a potential personalized medicine for rheumatoid arthritis GENEVA, August 5, 2014 /PRNewswire/ -- Novimmune SA, a company focused on the discovery and development of antibody-based drugs to benefit patients with inflammatory, auto-immune disorders, and cancer announces today the completion of a comprehensive Phase I clinical trial investigating the pharmacokinetics,...

2014-07-16 08:29:40

HERZLIYA, Israel, July 16, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, announced today that an overview of its hCDR1 peptide to treat patients with systemic lupus erythematosus (SLE) is included in an article titled, Novel Approaches to the Development of...

2014-07-03 08:23:49

MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting OX40, a co-stimulatory receptor on T cells - The antibody has successfully completed the Phase I enabling preclinical development program and a Phase I clinical trial application has been filed with The Netherlands authorities -...

2014-06-24 08:30:45

ORLANDO, Fla., June 24, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC: TNIB) ("TNI" or the "Company") a biotechnology company pioneering the development of innovative therapies for autoimmune diseases by combating these fatal diseases through the activation and modulation of the body's immune system, announced today that its Board of Directors had passed a resolution cancelling the previously announced 9:10 reverse split of its common stock, as per the 14A Information Statement filed...

Genetic Mapping Of Pig Whipworm May Lead To New Treatments For Autoimmune Disease
2014-06-20 11:20:38

Gerard LeBlond for redorbit.com - Your Universe Online According to an international team of researchers, a parasitic worm found in pigs could modify the human immune system to aid in the treatment of autoimmune diseases including inflammatory bowel disease and multiple sclerosis. The team consisted of 11 institutions from six different countries that presented the whole-genome sequence of the worm and published the study online in Nature Genetics. The human form of the whipworm infects...

2014-06-16 12:30:04

SAN DIEGO, June 16, 2014 /PRNewswire/ -- INOVA Diagnostics Inc., a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the global launch of QUANTA Lite Calprotectin, a new FDA cleared assay. This important assay, which aids in the diagnosis of Inflammatory Bowel Disease (IBD), can also help differentiate IBD from Irritable Bowel Syndrome (IBS) in conjunction with other laboratory and clinical findings. The accurate...

2014-06-12 23:09:12

New book provides first hand look at a fairly unknown autoimmune disease. ELGIN, Ill. (PRWEB) June 12, 2014 Imagine only being able to do one activity a day before being too tired to continue. For those who suffer from Chronic Fatigue Syndrome, situations like that are all too familiar. “My Battle with Chronic Fatigue Syndrome” is a detailed journey through the symptoms and impact of Chronic Fatigue Syndrome on not only the individuals, but also their caretakers. Told from the...

2014-06-11 08:30:04

Seattle Children's Research Institute and Kineta Launch the Alliance for Children's Therapeutics SEATTLE, June 11, 2014 /PRNewswire/ -- Seattle Children's Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children's Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, Type 1...

2014-06-03 12:36:41

ImaginAb Expands Portfolio for Immunotherapeutic Drug Development LOS ANGELES, June 3, 2014 /PRNewswire/ -- ImaginAb, Inc. and the Regents of the University of California, Los Angeles (UCLA) have executed a technology licensing agreement relating to novel immune cell-targeting agents for imaging with Positron Emission Tomography (PET). Inflammation and immune response play a fundamental role in a wide variety of diseases including cancer and autoimmune diseases. Under the agreement,...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related